Publication | Closed Access

A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)

MedicineMetronomic TherapyClinical TrialsPathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences